Longer acting GLP-1 receptor agonists and the potential for improved cardiovascular outcomes: a review of current literature
about
The future role of gut hormones in the treatment of obesityThe association of the treatment with glucagon-like peptide-1 receptor agonist exenatide or insulin with cardiovascular outcomes in patients with type 2 diabetes: a retrospective observational studyGLP-1 receptor agonists: Nonglycemic clinical effects in weight loss and beyond.Incretin-related drug therapy in heart failure.Can Bayliss and Starling gut hormones cure a worldwide pandemic?Fc-modified exenatide-loaded nanoparticles for oral delivery to improve hypoglycemic effects in mice.
P2860
Longer acting GLP-1 receptor agonists and the potential for improved cardiovascular outcomes: a review of current literature
description
article
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в травні 2013
@uk
name
Longer acting GLP-1 receptor a ...... a review of current literature
@en
Longer acting GLP-1 receptor a ...... a review of current literature
@nl
type
label
Longer acting GLP-1 receptor a ...... a review of current literature
@en
Longer acting GLP-1 receptor a ...... a review of current literature
@nl
prefLabel
Longer acting GLP-1 receptor a ...... a review of current literature
@en
Longer acting GLP-1 receptor a ...... a review of current literature
@nl
P2093
P2860
P356
P1476
Longer acting GLP-1 receptor a ...... a review of current literature
@en
P2093
Courtney Aavang Tibble
Robert R Henry
Tricia Santos Cavaiola
P2860
P304
P356
10.1586/EEM.13.20
P577
2013-05-01T00:00:00Z